Ignite Creation Date:
2025-12-24 @ 12:01 PM
Ignite Modification Date:
2025-12-27 @ 4:06 PM
Study NCT ID:
NCT01450761
Status:
COMPLETED
Last Update Posted:
2020-07-08
First Post:
2011-10-10
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone
Sponsor:
Bristol-Myers Squibb
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2015-03-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-17
Completion Date Type:
ACTUAL
First Submit Date:
2011-10-10
First Submit QC Date:
None
Study First Post Date:
2011-10-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-03-07
Results First Submit QC Date:
None
Results First Post Date:
2016-07-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-06
Last Update Post Date:
2020-07-08
Last Update Post Date Type:
ACTUAL